PL3743086T3 - Kompozycje zawierające szczepy bakteryjne - Google Patents

Kompozycje zawierające szczepy bakteryjne

Info

Publication number: PL3743086T3
Authority: PL; Poland
Prior art keywords: compositions; bacterial strains; strains; bacterial
Prior art date: 2018-05-11

Application number

PL19725068T

Other languages

English (en)

Inventor

Imke Elisabeth MULDER

Parthena FOTIADOU

Amy Beth HOLT

Suaad AHMED

Anna ETTORRE

Samantha YUILLE

Ted DINAN

John CRYAN

Original Assignee

4D Pharma Research Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-05-11

Filing date

2019-05-13

Publication date

2022-06-20

2018-06-25 Priority claimed from GBGB1810386.1A external-priority patent/GB201810386D0/en

2018-08-17 Priority claimed from GBGB1813460.1A external-priority patent/GB201813460D0/en

2018-10-29 Priority claimed from GBGB1817642.0A external-priority patent/GB201817642D0/en

2018-12-12 Priority claimed from GBGB1820264.8A external-priority patent/GB201820264D0/en

2018-12-12 Priority claimed from GBGB1820256.4A external-priority patent/GB201820256D0/en

2019-05-13 Application filed by 4D Pharma Research Limited filed Critical 4D Pharma Research Limited

2022-06-20 Publication of PL3743086T3 publication Critical patent/PL3743086T3/pl

Links

230000001580 bacterial effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Nutrition Science (AREA)
Developmental Biology & Embryology (AREA)
Biomedical Technology (AREA)
Virology (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Pediatric Medicine (AREA)
Physiology (AREA)
Biochemistry (AREA)

PL19725068T 2018-05-11 2019-05-13 Kompozycje zawierające szczepy bakteryjne PL3743086T3 (pl)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
EP18171893		2018-05-11
EP18178136		2018-06-15
GBGB1810386.1A GB201810386D0 (en)	2018-06-25	2018-06-25	Compositions comprising bacterial strains
GBGB1813460.1A GB201813460D0 (en)	2018-08-17	2018-08-17	Compositions comprising bacterial strains
GBGB1817642.0A GB201817642D0 (en)	2018-10-29	2018-10-29	Compositions comprising bacterial strains
GBGB1820264.8A GB201820264D0 (en)	2018-12-12	2018-12-12	Compositions comprising bacterial strains
GBGB1820256.4A GB201820256D0 (en)	2018-12-12	2018-12-12	Compositions comprising bacterial strains
PCT/EP2019/062238 WO2019215346A1 (en)	2018-05-11	2019-05-13	Compositions comprising bacterial strains
EP19725068.1A EP3743086B1 (en)	2018-05-11	2019-05-13	Compositions comprising bacterial strains

Publications (1)

Publication Number	Publication Date
PL3743086T3 true PL3743086T3 (pl)	2022-06-20

Family

ID=66597549

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL19725068T PL3743086T3 (pl)	2018-05-11	2019-05-13	Kompozycje zawierające szczepy bakteryjne

Country Status (22)

Country	Link
US (3)	US11419902B2 (pl)
EP (4)	EP4066845A1 (pl)
JP (3)	JP2021523895A (pl)
KR (2)	KR20210008391A (pl)
CN (2)	CN112601534A (pl)
AU (3)	AU2019267170A1 (pl)
BR (1)	BR112020022833A2 (pl)
CA (2)	CA3099209A1 (pl)
CY (1)	CY1125211T1 (pl)
DK (1)	DK3743086T3 (pl)
ES (1)	ES2916601T3 (pl)
HR (1)	HRP20220578T1 (pl)
IL (1)	IL278471B2 (pl)
LT (1)	LT3743086T (pl)
MD (1)	MD3743086T2 (pl)
MX (1)	MX2020012061A (pl)
PL (1)	PL3743086T3 (pl)
RS (1)	RS63273B1 (pl)
SG (2)	SG11202011031UA (pl)
SI (1)	SI3743086T1 (pl)
TW (2)	TW202014513A (pl)
WO (2)	WO2019215346A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA3051249A1 (en)	2017-01-31	2018-08-09	Kansas State University Research Foundation	Microbial cells, methods of producing the same, and uses thereof
PL3804737T3 (pl)	2017-06-14	2022-09-12	4D Pharma Research Limited	Kompozycje zawierające szczepy bakteryjne
UY37944A (es)	2017-10-20	2019-05-31	Ms Biotech Inc	Métodos para producir materiales vegetales ensilados usando megasphaera elsdenii
SI3743086T1 (sl) *	2018-05-11	2022-05-31	4D Pharma Research Limited	Sestavki, ki obsegajo bakterijske seve
US11541105B2 (en)	2018-06-01	2023-01-03	The Research Foundation For The State University Of New York	Compositions and methods for disrupting biofilm formation and maintenance
WO2020120716A1 (en) *	2018-12-12	2020-06-18	4D Pharma Research Limited	Compositions comprising bacterial strains
TW202216178A (zh) *	2020-06-11	2022-05-01	美商艾弗洛生物科技股份有限公司	使用巨型球菌屬物種治療疾病及障礙之組成物及方法
CN112980878B (zh) *	2021-02-04	2023-03-31	中国农业科学院兰州兽医研究所	Hdac8基因敲除的bhk-21细胞系及其构建方法和应用
CN112877275B (zh) *	2021-02-04	2023-03-31	中国农业科学院兰州兽医研究所	Hdac2基因敲除的bhk-21细胞系及其构建方法和应用
KR102551061B1 (ko) *	2022-05-26	2023-07-03	중앙대학교 산학협력단	Saha를 유효성분으로 포함하는 살모넬라 속 균주에 의한 바이오필름 생성 저해용 조성물

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5557520A (en) *	1978-10-26	1980-04-28	Nisshin Flour Milling Co Ltd	Preparation of carcinostatic substance
JPWO2002080947A1 (ja)	2001-04-06	2004-07-29	株式会社京都動物検査センター	酪酸転化能を有する菌含有組成物及びそれを用いた消化管の乳酸過多及び大腸がんの予防・治療方法
GB0127916D0 (en)	2001-11-21	2002-01-16	Rowett Res Inst	Method
US20040005304A1 (en)	2002-07-08	2004-01-08	Mak Wood, Inc.	Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
GB0307026D0 (en) *	2003-03-27	2003-04-30	Rowett Res Inst	Bacterial supplement
AU2004270150C1 (en)	2003-08-29	2011-07-14	Merck Hdac Research, Llc	Combination methods of treating cancer
GB201112091D0 (en)	2011-07-14	2011-08-31	Gt Biolog Ltd	Bacterial strains isolated from pigs
GB201117313D0 (en)	2011-10-07	2011-11-16	Gt Biolog Ltd	Bacterium for use in medicine
NZ709392A (en)	2012-11-23	2016-10-28	Seres Therapeutics Inc	Synergistic bacterial compositions and methods of production and use thereof
EP2951283A4 (en)	2013-02-04	2017-01-25	Seres Therapeutics, Inc.	Compositions and methods
GB201306536D0 (en)	2013-04-10	2013-05-22	Gt Biolog Ltd	Polypeptide and immune modulation
JP6585041B2 (ja) *	2013-07-18	2019-10-02	ベイラーカレッジオブメディスンＢａｙｌｏｒＣｏｌｌｅｇｅＯｆＭｅｄｉｃｉｎｅ	免疫細胞の能力を増強する方法
CN104415060A (zh) *	2013-08-30	2015-03-18	深圳华大基因科技有限公司	可食用组合物及其制备方法和用途
WO2015038731A1 (en)	2013-09-12	2015-03-19	The Johns Hopkins University	Biofilm formation to define risk for colon cancer
AU2014352643A1 (en)	2013-11-25	2016-06-30	Seres Therapeutics, Inc.	Synergistic bacterial compositions and methods of production and use thereof
US9650654B2 (en) *	2014-06-25	2017-05-16	William Marsh Rice University	Making C4+ products in bacteria
US10366793B2 (en) *	2014-10-21	2019-07-30	uBiome, Inc.	Method and system for characterizing microorganism-related conditions
WO2016073381A1 (en) *	2014-11-03	2016-05-12	Cerus Corporation	Compositions and methods for improved car-t cell therapies
MA41020A (fr) *	2014-11-25	2017-10-03	Evelo Biosciences Inc	Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
CN107405321A (zh) *	2015-01-23	2017-11-28	坦普尔大学	短链脂肪酸在癌症预防中的应用
WO2016149449A1 (en)	2015-03-18	2016-09-22	Tufts University	Compositions and methods for preventing colorectal cancer
MA41060B1 (fr)	2015-06-15	2019-11-29	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
GB2561748B (en) *	2015-11-20	2019-05-08	4D Pharma Res Ltd	Compositions comprising bacterial strains
WO2017091783A2 (en) *	2015-11-24	2017-06-01	Seres Therapeutics, Inc.	Designed bacterial compositions
MX2018008523A (es) *	2016-01-11	2019-05-15	3Plw Ltd	Bacterias que utilizan el acido lactico geneticamente modificadas para secretar enzimas degradantes de los polisacaridos.
CN107028985A (zh) *	2016-02-04	2017-08-11	深圳华大基因研究院	厚壁菌类益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
US20190125808A1 (en) *	2016-03-30	2019-05-02	The Trustees Of Columbia University In The City Of New York	Methods of preventing, treating and detecting colorectal cancer using butyrate producing bacteria
US9999641B2 (en) *	2016-06-14	2018-06-19	Vedanta Biosciences, Inc.	Treatment of clostridium difficile infection
MX2019003447A (es) *	2016-09-27	2019-08-29	Univ Texas	Metodos para mejorar la terapia de bloqueo del punto de control inmune mediante la modulacion del microbioma.
US11571446B2 (en)	2016-11-18	2023-02-07	Sanford Bumham Prebys Medical Discovery Institute	Gut microbiota and treatment of cancer
WO2018112363A1 (en)	2016-12-16	2018-06-21	Evelo Biosciences, Inc.	Methods of treating cancer using parabacteroides
WO2018112365A2 (en)	2016-12-16	2018-06-21	Evelo Biosciences, Inc.	Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii
CA3066189A1 (en) *	2017-06-14	2018-12-20	4D Pharma Research Limited	Compositions comprising bacterial strains
PL3804737T3 (pl) *	2017-06-14	2022-09-12	4D Pharma Research Limited	Kompozycje zawierające szczepy bakteryjne
SI3743086T1 (sl) *	2018-05-11	2022-05-31	4D Pharma Research Limited	Sestavki, ki obsegajo bakterijske seve
SG11202106230XA (en)	2018-12-12	2021-07-29	4D Pharma Res Ltd	Compositions comprising bacterial strains

2019
- 2019-05-13 SI SI201930216T patent/SI3743086T1/sl unknown
- 2019-05-13 EP EP22162425.7A patent/EP4066845A1/en active Pending
- 2019-05-13 CA CA3099209A patent/CA3099209A1/en active Pending
- 2019-05-13 WO PCT/EP2019/062238 patent/WO2019215346A1/en active Search and Examination
- 2019-05-13 JP JP2020562128A patent/JP2021523895A/ja active Pending
- 2019-05-13 AU AU2019267170A patent/AU2019267170A1/en not_active Abandoned
- 2019-05-13 RS RS20220465A patent/RS63273B1/sr unknown
- 2019-05-13 HR HRP20220578TT patent/HRP20220578T1/hr unknown
- 2019-05-13 EP EP19725067.3A patent/EP3790564A1/en not_active Withdrawn
- 2019-05-13 MD MDE20201221T patent/MD3743086T2/ro unknown
- 2019-05-13 EP EP19725068.1A patent/EP3743086B1/en active Active
- 2019-05-13 CN CN201980031147.8A patent/CN112601534A/zh active Pending
- 2019-05-13 LT LTEPPCT/EP2019/062238T patent/LT3743086T/lt unknown
- 2019-05-13 AU AU2019267171A patent/AU2019267171A1/en not_active Abandoned
- 2019-05-13 PL PL19725068T patent/PL3743086T3/pl unknown
- 2019-05-13 DK DK19725068.1T patent/DK3743086T3/da active
- 2019-05-13 KR KR1020207035242A patent/KR20210008391A/ko not_active Application Discontinuation
- 2019-05-13 BR BR112020022833-8A patent/BR112020022833A2/pt unknown
- 2019-05-13 TW TW108116449A patent/TW202014513A/zh unknown
- 2019-05-13 SG SG11202011031UA patent/SG11202011031UA/en unknown
- 2019-05-13 SG SG11202011028SA patent/SG11202011028SA/en unknown
- 2019-05-13 TW TW108116469A patent/TW202011975A/zh unknown
- 2019-05-13 ES ES19725068T patent/ES2916601T3/es active Active
- 2019-05-13 CN CN201980031512.5A patent/CN112512539A/zh active Pending
- 2019-05-13 KR KR1020207035244A patent/KR20210008393A/ko unknown
- 2019-05-13 CA CA3098971A patent/CA3098971A1/en active Pending
- 2019-05-13 MX MX2020012061A patent/MX2020012061A/es unknown
- 2019-05-13 EP EP22162255.8A patent/EP4056192A1/en active Pending
- 2019-05-13 WO PCT/EP2019/062236 patent/WO2019215345A1/en active Search and Examination
- 2019-05-13 JP JP2020545563A patent/JP7058449B2/ja active Active
2020
- 2020-09-04 US US17/013,026 patent/US11419902B2/en active Active
- 2020-11-03 IL IL278471A patent/IL278471B2/en unknown
- 2020-11-11 US US17/095,427 patent/US20210275605A1/en not_active Abandoned
2022
- 2022-04-05 JP JP2022062741A patent/JP2022088631A/ja active Pending
- 2022-05-27 CY CY20221100367T patent/CY1125211T1/el unknown
- 2022-06-23 US US17/847,336 patent/US20230158083A1/en not_active Abandoned
2023
- 2023-02-03 AU AU2023200562A patent/AU2023200562A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TW202014513A (zh)	2020-04-16
CY1125211T1 (el)	2024-02-16
US20210052671A1 (en)	2021-02-25
SG11202011031UA (en)	2020-12-30
US20230158083A1 (en)	2023-05-25
MX2020012061A (es)	2022-10-13
ES2916601T3 (es)	2022-07-04
AU2023200562A1 (en)	2023-03-02
JP2021517560A (ja)	2021-07-26
KR20210008393A (ko)	2021-01-21
MD3743086T2 (ro)	2022-12-31
EP4056192A1 (en)	2022-09-14
IL278471A (pl)	2020-12-31
IL278471B2 (en)	2023-08-01
WO2019215345A1 (en)	2019-11-14
CA3099209A1 (en)	2019-11-14
HRP20220578T1 (hr)	2022-09-16
EP4066845A1 (en)	2022-10-05
EP3790564A1 (en)	2021-03-17
EP3743086B1 (en)	2022-03-16
AU2019267171A1 (en)	2021-01-07
IL278471B1 (en)	2023-04-01
US11419902B2 (en)	2022-08-23
CN112601534A (zh)	2021-04-02
AU2019267170A1 (en)	2021-01-07
WO2019215346A1 (en)	2019-11-14
SI3743086T1 (sl)	2022-05-31
TW202011975A (zh)	2020-04-01
BR112020022833A2 (pt)	2021-02-02
JP2022088631A (ja)	2022-06-14
LT3743086T (lt)	2022-06-10
KR20210008391A (ko)	2021-01-21
CN112512539A (zh)	2021-03-16
US20210275605A1 (en)	2021-09-09
SG11202011028SA (en)	2020-12-30
CA3098971A1 (en)	2019-11-14
DK3743086T3 (da)	2022-05-02
JP7058449B2 (ja)	2022-04-22
EP3743086A1 (en)	2020-12-02
RS63273B1 (sr)	2022-06-30
JP2021523895A (ja)	2021-09-09

Publication	Publication Date	Title
IL283751A (en)	2021-07-29	Compositions comprising bacterial strains
SG11202011031UA (en)	2020-12-30	Compositions comprising bacterial strains
IL277422A (en)	2020-11-30	compounds containing bacterial strains
IL281951A (en)	2021-05-31	compounds containing bacterial strains
IL280895A (en)	2021-04-29	compounds containing bacterial strains
IL279963A (en)	2021-03-01	compounds containing bacterial strains
IL279339A (en)	2021-01-31	compounds containing bacterial strains
IL282439A (en)	2021-06-30	compounds containing bacterial strains
IL279724B (en)	2022-05-01	compounds containing bacterial strains
PT3723777T (pt)	2021-06-21	Composições que compreendem estirpes bacterianas
PT3743086T (pt)	2022-05-25	Composições compreendendo estirpes bacterianas
GB201820745D0 (en)	2019-01-30	Compositions comprising bacterial strains
GB201820744D0 (en)	2019-01-30	Compositions comprising bacterial strains
GB201820264D0 (en)	2019-01-30	Compositions comprising bacterial strains
GB201820256D0 (en)	2019-01-30	Compositions comprising bacterial strains
GB201820261D0 (en)	2019-01-30	Compositions comprising bacterial strains
GB201820230D0 (en)	2019-01-23	Compositions comprising bacterial strains
GB201817648D0 (en)	2018-12-12	Compositions comprising bacterial strains
GB201817642D0 (en)	2018-12-12	Compositions comprising bacterial strains
GB201817641D0 (en)	2018-12-12	Compositions comprising bacterial strains
GB201814836D0 (en)	2018-10-24	Compositions comprising bacterial strains
GB201813423D0 (en)	2018-10-03	Compositions comprising bacterial strains
GB201813460D0 (en)	2018-10-03	Compositions comprising bacterial strains
GB201812378D0 (en)	2018-09-12	Compositions comprising bacterial strains
GB201811900D0 (en)	2018-09-05	Compositions comprising bacterial strains